Global BCG Vaccine

BCG Vaccine Comprehensive Study by Type (Immune BCG, Therapy BCG), Application (Hospitals, Clinics, Others), Demographics (Pediatrics (0-18 Years), Adults (19-35 Years)) Players and Region - Global Market Outlook to 2026

BCG Vaccine Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is BCG Vaccine Market Scope?
Bacillus Calmette–Guérin (BCG) vaccine is defined as the vaccine, which is mainly used against tuberculosis. The various functions of using Bacillus Calmette–Guérin (BCG) vaccine in the human body, such as to prevent childhood tuberculosis meningitis, military infection, kids at high risk are usually immunized, and others. The increase in prevalence of tuberculosis and technological advancement in the field of vaccine research are some of the major drivers which are propelling the growth of the market

The BCG Vaccine market study is being classified by Type (Immune BCG and Therapy BCG), by Application (Hospitals, Clinics and Others) and major geographies with country level break-up.

Merck & Co., Inc., (United States), Sanofi Pasteur,(France), Japan BCG Laboratory (Japan), China National Biotec Group (China), Serum Institute of India Pvt. Ltd., (India), InterVax Ltd., (Canada), GreenSignal Bio Pharma Limited (India) and Statens Serum Institut. (Denmark) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global BCG Vaccine market by Type, Application and Region.

On the basis of geography, the market of BCG Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020.

In the year 2021, Annual Scientific Sessions of the American Diabetes Association and researchers from Massachusetts General Hospital revealed a positive update on the trials of BCG vaccinated to safely and significantly lower blood sugars.
On March 2013, as per an article published by the National Center for Biotechnology Information, that the adverse reactions to BCG vaccination are unusual, provided that correct immunization techniques should be used and that those to be vaccinated should properly select

Influencing Market Trend
  • Technology Advancement of the BCG vaccine

Market Drivers
  • Increase in Government Initiatives towards BCG Vaccine
  • Numerous Company Investments Deployed For Research and Development

Opportunities
  • Rising Demand from Emerging Economics Such as India, China and Others

Restraints
  • Side Effects of BCG Vaccine

Challenges
  • Lack of awareness regarding the benefits of BCG vaccine


Key Target Audience
Manufacturers of Bacillus Calmette–Guérin (BCG) vaccine, Suppliers of Bacillus Calmette–Guérin (BCG) vaccine part, Wholesalers, distributors and retailers of Bacillus Calmette–Guérin (BCG) vaccine, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Immune BCG
  • Therapy BCG
By Application
  • Hospitals
  • Clinics
  • Others
By Demographics
  • Pediatrics (0-18 Years)
  • Adults (19-35 Years)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Government Initiatives towards BCG Vaccine
      • 3.2.2. Numerous Company Investments Deployed For Research and Development
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness regarding the benefits of BCG vaccine
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement of the BCG vaccine
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global BCG Vaccine, by Type, Application, Demographics and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global BCG Vaccine (Value)
      • 5.2.1. Global BCG Vaccine by: Type (Value)
        • 5.2.1.1. Immune BCG
        • 5.2.1.2. Therapy BCG
      • 5.2.2. Global BCG Vaccine by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global BCG Vaccine by: Demographics (Value)
        • 5.2.3.1. Pediatrics (0-18 Years)
        • 5.2.3.2. Adults (19-35 Years)
      • 5.2.4. Global BCG Vaccine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. BCG Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co., Inc., (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi Pasteur,(France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Japan BCG Laboratory (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. China National Biotec Group (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Serum Institute of India Pvt. Ltd., (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. InterVax Ltd., (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GreenSignal Bio Pharma Limited (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Statens Serum Institut. (Denmark)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global BCG Vaccine Sale, by Type, Application, Demographics and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global BCG Vaccine (Value)
      • 7.2.1. Global BCG Vaccine by: Type (Value)
        • 7.2.1.1. Immune BCG
        • 7.2.1.2. Therapy BCG
      • 7.2.2. Global BCG Vaccine by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global BCG Vaccine by: Demographics (Value)
        • 7.2.3.1. Pediatrics (0-18 Years)
        • 7.2.3.2. Adults (19-35 Years)
      • 7.2.4. Global BCG Vaccine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. BCG Vaccine: by Type(USD Million)
  • Table 2. BCG Vaccine Immune BCG , by Region USD Million (2015-2020)
  • Table 3. BCG Vaccine Therapy BCG , by Region USD Million (2015-2020)
  • Table 4. BCG Vaccine: by Application(USD Million)
  • Table 5. BCG Vaccine Hospitals , by Region USD Million (2015-2020)
  • Table 6. BCG Vaccine Clinics , by Region USD Million (2015-2020)
  • Table 7. BCG Vaccine Others , by Region USD Million (2015-2020)
  • Table 8. BCG Vaccine: by Demographics(USD Million)
  • Table 9. BCG Vaccine Pediatrics (0-18 Years) , by Region USD Million (2015-2020)
  • Table 10. BCG Vaccine Adults (19-35 Years) , by Region USD Million (2015-2020)
  • Table 11. South America BCG Vaccine, by Country USD Million (2015-2020)
  • Table 12. South America BCG Vaccine, by Type USD Million (2015-2020)
  • Table 13. South America BCG Vaccine, by Application USD Million (2015-2020)
  • Table 14. South America BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 15. Brazil BCG Vaccine, by Type USD Million (2015-2020)
  • Table 16. Brazil BCG Vaccine, by Application USD Million (2015-2020)
  • Table 17. Brazil BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 18. Argentina BCG Vaccine, by Type USD Million (2015-2020)
  • Table 19. Argentina BCG Vaccine, by Application USD Million (2015-2020)
  • Table 20. Argentina BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 21. Rest of South America BCG Vaccine, by Type USD Million (2015-2020)
  • Table 22. Rest of South America BCG Vaccine, by Application USD Million (2015-2020)
  • Table 23. Rest of South America BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 24. Asia Pacific BCG Vaccine, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific BCG Vaccine, by Type USD Million (2015-2020)
  • Table 26. Asia Pacific BCG Vaccine, by Application USD Million (2015-2020)
  • Table 27. Asia Pacific BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 28. China BCG Vaccine, by Type USD Million (2015-2020)
  • Table 29. China BCG Vaccine, by Application USD Million (2015-2020)
  • Table 30. China BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 31. Japan BCG Vaccine, by Type USD Million (2015-2020)
  • Table 32. Japan BCG Vaccine, by Application USD Million (2015-2020)
  • Table 33. Japan BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 34. India BCG Vaccine, by Type USD Million (2015-2020)
  • Table 35. India BCG Vaccine, by Application USD Million (2015-2020)
  • Table 36. India BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 37. South Korea BCG Vaccine, by Type USD Million (2015-2020)
  • Table 38. South Korea BCG Vaccine, by Application USD Million (2015-2020)
  • Table 39. South Korea BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 40. Taiwan BCG Vaccine, by Type USD Million (2015-2020)
  • Table 41. Taiwan BCG Vaccine, by Application USD Million (2015-2020)
  • Table 42. Taiwan BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 43. Australia BCG Vaccine, by Type USD Million (2015-2020)
  • Table 44. Australia BCG Vaccine, by Application USD Million (2015-2020)
  • Table 45. Australia BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 46. Rest of Asia-Pacific BCG Vaccine, by Type USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific BCG Vaccine, by Application USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 49. Europe BCG Vaccine, by Country USD Million (2015-2020)
  • Table 50. Europe BCG Vaccine, by Type USD Million (2015-2020)
  • Table 51. Europe BCG Vaccine, by Application USD Million (2015-2020)
  • Table 52. Europe BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 53. Germany BCG Vaccine, by Type USD Million (2015-2020)
  • Table 54. Germany BCG Vaccine, by Application USD Million (2015-2020)
  • Table 55. Germany BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 56. France BCG Vaccine, by Type USD Million (2015-2020)
  • Table 57. France BCG Vaccine, by Application USD Million (2015-2020)
  • Table 58. France BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 59. Italy BCG Vaccine, by Type USD Million (2015-2020)
  • Table 60. Italy BCG Vaccine, by Application USD Million (2015-2020)
  • Table 61. Italy BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 62. United Kingdom BCG Vaccine, by Type USD Million (2015-2020)
  • Table 63. United Kingdom BCG Vaccine, by Application USD Million (2015-2020)
  • Table 64. United Kingdom BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 65. Netherlands BCG Vaccine, by Type USD Million (2015-2020)
  • Table 66. Netherlands BCG Vaccine, by Application USD Million (2015-2020)
  • Table 67. Netherlands BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 68. Rest of Europe BCG Vaccine, by Type USD Million (2015-2020)
  • Table 69. Rest of Europe BCG Vaccine, by Application USD Million (2015-2020)
  • Table 70. Rest of Europe BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 71. MEA BCG Vaccine, by Country USD Million (2015-2020)
  • Table 72. MEA BCG Vaccine, by Type USD Million (2015-2020)
  • Table 73. MEA BCG Vaccine, by Application USD Million (2015-2020)
  • Table 74. MEA BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 75. Middle East BCG Vaccine, by Type USD Million (2015-2020)
  • Table 76. Middle East BCG Vaccine, by Application USD Million (2015-2020)
  • Table 77. Middle East BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 78. Africa BCG Vaccine, by Type USD Million (2015-2020)
  • Table 79. Africa BCG Vaccine, by Application USD Million (2015-2020)
  • Table 80. Africa BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 81. North America BCG Vaccine, by Country USD Million (2015-2020)
  • Table 82. North America BCG Vaccine, by Type USD Million (2015-2020)
  • Table 83. North America BCG Vaccine, by Application USD Million (2015-2020)
  • Table 84. North America BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 85. United States BCG Vaccine, by Type USD Million (2015-2020)
  • Table 86. United States BCG Vaccine, by Application USD Million (2015-2020)
  • Table 87. United States BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 88. Canada BCG Vaccine, by Type USD Million (2015-2020)
  • Table 89. Canada BCG Vaccine, by Application USD Million (2015-2020)
  • Table 90. Canada BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 91. Mexico BCG Vaccine, by Type USD Million (2015-2020)
  • Table 92. Mexico BCG Vaccine, by Application USD Million (2015-2020)
  • Table 93. Mexico BCG Vaccine, by Demographics USD Million (2015-2020)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. BCG Vaccine: by Type(USD Million)
  • Table 103. BCG Vaccine Immune BCG , by Region USD Million (2021-2026)
  • Table 104. BCG Vaccine Therapy BCG , by Region USD Million (2021-2026)
  • Table 105. BCG Vaccine: by Application(USD Million)
  • Table 106. BCG Vaccine Hospitals , by Region USD Million (2021-2026)
  • Table 107. BCG Vaccine Clinics , by Region USD Million (2021-2026)
  • Table 108. BCG Vaccine Others , by Region USD Million (2021-2026)
  • Table 109. BCG Vaccine: by Demographics(USD Million)
  • Table 110. BCG Vaccine Pediatrics (0-18 Years) , by Region USD Million (2021-2026)
  • Table 111. BCG Vaccine Adults (19-35 Years) , by Region USD Million (2021-2026)
  • Table 112. South America BCG Vaccine, by Country USD Million (2021-2026)
  • Table 113. South America BCG Vaccine, by Type USD Million (2021-2026)
  • Table 114. South America BCG Vaccine, by Application USD Million (2021-2026)
  • Table 115. South America BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 116. Brazil BCG Vaccine, by Type USD Million (2021-2026)
  • Table 117. Brazil BCG Vaccine, by Application USD Million (2021-2026)
  • Table 118. Brazil BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 119. Argentina BCG Vaccine, by Type USD Million (2021-2026)
  • Table 120. Argentina BCG Vaccine, by Application USD Million (2021-2026)
  • Table 121. Argentina BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 122. Rest of South America BCG Vaccine, by Type USD Million (2021-2026)
  • Table 123. Rest of South America BCG Vaccine, by Application USD Million (2021-2026)
  • Table 124. Rest of South America BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 125. Asia Pacific BCG Vaccine, by Country USD Million (2021-2026)
  • Table 126. Asia Pacific BCG Vaccine, by Type USD Million (2021-2026)
  • Table 127. Asia Pacific BCG Vaccine, by Application USD Million (2021-2026)
  • Table 128. Asia Pacific BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 129. China BCG Vaccine, by Type USD Million (2021-2026)
  • Table 130. China BCG Vaccine, by Application USD Million (2021-2026)
  • Table 131. China BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 132. Japan BCG Vaccine, by Type USD Million (2021-2026)
  • Table 133. Japan BCG Vaccine, by Application USD Million (2021-2026)
  • Table 134. Japan BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 135. India BCG Vaccine, by Type USD Million (2021-2026)
  • Table 136. India BCG Vaccine, by Application USD Million (2021-2026)
  • Table 137. India BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 138. South Korea BCG Vaccine, by Type USD Million (2021-2026)
  • Table 139. South Korea BCG Vaccine, by Application USD Million (2021-2026)
  • Table 140. South Korea BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 141. Taiwan BCG Vaccine, by Type USD Million (2021-2026)
  • Table 142. Taiwan BCG Vaccine, by Application USD Million (2021-2026)
  • Table 143. Taiwan BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 144. Australia BCG Vaccine, by Type USD Million (2021-2026)
  • Table 145. Australia BCG Vaccine, by Application USD Million (2021-2026)
  • Table 146. Australia BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 147. Rest of Asia-Pacific BCG Vaccine, by Type USD Million (2021-2026)
  • Table 148. Rest of Asia-Pacific BCG Vaccine, by Application USD Million (2021-2026)
  • Table 149. Rest of Asia-Pacific BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 150. Europe BCG Vaccine, by Country USD Million (2021-2026)
  • Table 151. Europe BCG Vaccine, by Type USD Million (2021-2026)
  • Table 152. Europe BCG Vaccine, by Application USD Million (2021-2026)
  • Table 153. Europe BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 154. Germany BCG Vaccine, by Type USD Million (2021-2026)
  • Table 155. Germany BCG Vaccine, by Application USD Million (2021-2026)
  • Table 156. Germany BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 157. France BCG Vaccine, by Type USD Million (2021-2026)
  • Table 158. France BCG Vaccine, by Application USD Million (2021-2026)
  • Table 159. France BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 160. Italy BCG Vaccine, by Type USD Million (2021-2026)
  • Table 161. Italy BCG Vaccine, by Application USD Million (2021-2026)
  • Table 162. Italy BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 163. United Kingdom BCG Vaccine, by Type USD Million (2021-2026)
  • Table 164. United Kingdom BCG Vaccine, by Application USD Million (2021-2026)
  • Table 165. United Kingdom BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 166. Netherlands BCG Vaccine, by Type USD Million (2021-2026)
  • Table 167. Netherlands BCG Vaccine, by Application USD Million (2021-2026)
  • Table 168. Netherlands BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 169. Rest of Europe BCG Vaccine, by Type USD Million (2021-2026)
  • Table 170. Rest of Europe BCG Vaccine, by Application USD Million (2021-2026)
  • Table 171. Rest of Europe BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 172. MEA BCG Vaccine, by Country USD Million (2021-2026)
  • Table 173. MEA BCG Vaccine, by Type USD Million (2021-2026)
  • Table 174. MEA BCG Vaccine, by Application USD Million (2021-2026)
  • Table 175. MEA BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 176. Middle East BCG Vaccine, by Type USD Million (2021-2026)
  • Table 177. Middle East BCG Vaccine, by Application USD Million (2021-2026)
  • Table 178. Middle East BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 179. Africa BCG Vaccine, by Type USD Million (2021-2026)
  • Table 180. Africa BCG Vaccine, by Application USD Million (2021-2026)
  • Table 181. Africa BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 182. North America BCG Vaccine, by Country USD Million (2021-2026)
  • Table 183. North America BCG Vaccine, by Type USD Million (2021-2026)
  • Table 184. North America BCG Vaccine, by Application USD Million (2021-2026)
  • Table 185. North America BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 186. United States BCG Vaccine, by Type USD Million (2021-2026)
  • Table 187. United States BCG Vaccine, by Application USD Million (2021-2026)
  • Table 188. United States BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 189. Canada BCG Vaccine, by Type USD Million (2021-2026)
  • Table 190. Canada BCG Vaccine, by Application USD Million (2021-2026)
  • Table 191. Canada BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 192. Mexico BCG Vaccine, by Type USD Million (2021-2026)
  • Table 193. Mexico BCG Vaccine, by Application USD Million (2021-2026)
  • Table 194. Mexico BCG Vaccine, by Demographics USD Million (2021-2026)
  • Table 195. Research Programs/Design for This Report
  • Table 196. Key Data Information from Secondary Sources
  • Table 197. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global BCG Vaccine: by Type USD Million (2015-2020)
  • Figure 5. Global BCG Vaccine: by Application USD Million (2015-2020)
  • Figure 6. Global BCG Vaccine: by Demographics USD Million (2015-2020)
  • Figure 7. South America BCG Vaccine Share (%), by Country
  • Figure 8. Asia Pacific BCG Vaccine Share (%), by Country
  • Figure 9. Europe BCG Vaccine Share (%), by Country
  • Figure 10. MEA BCG Vaccine Share (%), by Country
  • Figure 11. North America BCG Vaccine Share (%), by Country
  • Figure 12. Global BCG Vaccine share by Players 2020 (%)
  • Figure 13. Global BCG Vaccine share by Players (Top 3) 2020(%)
  • Figure 14. Global BCG Vaccine share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Merck & Co., Inc., (United States) Revenue, Net Income and Gross profit
  • Figure 17. Merck & Co., Inc., (United States) Revenue: by Geography 2020
  • Figure 18. Sanofi Pasteur,(France) Revenue, Net Income and Gross profit
  • Figure 19. Sanofi Pasteur,(France) Revenue: by Geography 2020
  • Figure 20. Japan BCG Laboratory (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Japan BCG Laboratory (Japan) Revenue: by Geography 2020
  • Figure 22. China National Biotec Group (China) Revenue, Net Income and Gross profit
  • Figure 23. China National Biotec Group (China) Revenue: by Geography 2020
  • Figure 24. Serum Institute of India Pvt. Ltd., (India) Revenue, Net Income and Gross profit
  • Figure 25. Serum Institute of India Pvt. Ltd., (India) Revenue: by Geography 2020
  • Figure 26. InterVax Ltd., (Canada) Revenue, Net Income and Gross profit
  • Figure 27. InterVax Ltd., (Canada) Revenue: by Geography 2020
  • Figure 28. GreenSignal Bio Pharma Limited (India) Revenue, Net Income and Gross profit
  • Figure 29. GreenSignal Bio Pharma Limited (India) Revenue: by Geography 2020
  • Figure 30. Statens Serum Institut. (Denmark) Revenue, Net Income and Gross profit
  • Figure 31. Statens Serum Institut. (Denmark) Revenue: by Geography 2020
  • Figure 32. Global BCG Vaccine: by Type USD Million (2021-2026)
  • Figure 33. Global BCG Vaccine: by Application USD Million (2021-2026)
  • Figure 34. Global BCG Vaccine: by Demographics USD Million (2021-2026)
  • Figure 35. South America BCG Vaccine Share (%), by Country
  • Figure 36. Asia Pacific BCG Vaccine Share (%), by Country
  • Figure 37. Europe BCG Vaccine Share (%), by Country
  • Figure 38. MEA BCG Vaccine Share (%), by Country
  • Figure 39. North America BCG Vaccine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck & Co., Inc., (United States)
  • Sanofi Pasteur,(France)
  • Japan BCG Laboratory (Japan)
  • China National Biotec Group (China)
  • Serum Institute of India Pvt. Ltd., (India)
  • InterVax Ltd., (Canada)
  • GreenSignal Bio Pharma Limited (India)
  • Statens Serum Institut. (Denmark)
Select User Access Type

Key Highlights of Report


Jul 2021 212 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global BCG Vaccine Quantitative research analysis
Global BCG Vaccine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global BCG Vaccine market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global BCG Vaccine market are Merck & Co., Inc., (United States), Sanofi Pasteur,(France), Japan BCG Laboratory (Japan), China National Biotec Group (China), Serum Institute of India Pvt. Ltd., (India), InterVax Ltd., (Canada), GreenSignal Bio Pharma Limited (India) and Statens Serum Institut. (Denmark), to name a few.
In this highly competitive & fast evolving BCG Vaccine industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global BCG Vaccine Report?

Have a Query? Click Here

Other Related Reports

Liver Detox Comprehensive Study by Type (Tablets, Capsules, Liquid and Sprays, Others), Distribution Channel (Supermarket, Convenience Stores, Specialty Stores, Online Stores, Other), End User (Indiv...
$ 3350
Antihypertensive Drugs Comprehensive Study by Disease Type (Primary Hypertension, Secondary Hypertension), End-users (Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacy, Hospital Phar...
$ 3750
Legal Cannabis Comprehensive Study by Type (Indoor, Greenhouse), Application (Chronic Pain, Mental Disorders, Cancer, Others), End-Users (Healthcare Industry, Recreational Industry, Others) Players a...
$ 3500
Dual Chamber Syringe Comprehensive Study by Application (Liquid/Powder, Liquid/Liquid), Indication (Hemophilia, Schizophrenia, Diabetes, Erectile Dysfunction, Endometriosis, Others), Size (<1 ml, 1 m...
$ 3650
Limulus Amebocyte Lysate Comprehensive Study by Type (Bacterial Endotoxins, Pyrogens - Biological Test), Application (Drug Testing, Clinical Diagnosis, Others), End User (Hospitals, Clinics, Healthca...
$ 3450
Fragment-based Drug Discovery Comprehensive Study by Type (Fragment Screening, Fragment Optimization), End-users (Academic and Research Institutions, Biopharmaceutical Companies, Contract Research Or...
$ 3500